Veracyte, Inc. (NASDAQ: VCYT) Stock Information | RedChip

Veracyte, Inc. (NASDAQ: VCYT)


$43.7500
-0.0300 ( +2.97% ) 633.1K

Veracyte Inc is a genomic diagnostics company. It provides genomic diagnostic products and services to improve patient care against diseases such as thyroid cancer, lung cancer, and idiopathic pulmonary fibrosis. The firm's product portfolio consists of products such as Afirma analysis, Percepta, Envisia, and others.

Market Data


Open


$43.7500

Previous close


$43.7800

Volume


633.1K

Market cap


$3.39B

Day range


$41.8020 - $43.9490

52 week range


$18.6100 - $46.0000

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Nov 21, 2024
4 Insider transactions 1 Nov 14, 2024
4 Insider transactions 1 Nov 14, 2024
10-q Quarterly Reports 68 Nov 07, 2024
8-k 8K-related 15 Nov 06, 2024
4 Insider transactions 1 Sep 23, 2024
4 Insider transactions 1 Sep 06, 2024
3 Insider transactions 2 Sep 04, 2024
8-k 8K-related 13 Sep 04, 2024
4 Insider transactions 1 Sep 04, 2024

Latest News